Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers
International Journal of Molecular Sciences · 26.03.2024 · 25 (7) · 3678
DOI: 10.3390/ijms25073678 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.03.2024. Verfasst von Harald Rupprecht und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Angiology and Rheumatology, Klinikum Bayreuth GmbH, 95445 Bayreuth, Germany. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Federal Ministry of Education and Research, Bundesministerium für Bildung und Forschung (BMBF; Federal Ministry of Education and Research).
Abstract (Originalsprache)
Effective management of chronic kidney disease (CKD), a major health problem worldwide, requires accurate and timely diagnosis, prognosis of progression, assessment of therapeutic efficacy, and, ideally, prediction of drug response. Multiple biomarkers and algorithms for evaluating specific aspects of CKD have been proposed in the literature, many of which are based on a small number of samples. Based on the evidence presented in relevant studies, a comprehensive overview of the different biomarkers applicable for clinical implementation is lacking. This review aims to compile information on the non-invasive diagnostic, prognostic, and predictive biomarkers currently available for the management of CKD and provide guidance on the application of these biomarkers. We specifically focus on biomarkers that have demonstrated added value in prospective studies or those based on prospectively collected samples including at least 100 subjects. Published data demonstrate that several valid non-invasive biomarkers of potential value in the management of CKD are currently available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Angiology and Rheumatology, Klinikum Bayreuth GmbH, 95445 Bayreuth, Germany.
- Department of Nephrology, Medizincampus Oberfranken, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
- Kuratorium for Dialysis and Transplantation (KfH) Bayreuth, 95445 Bayreuth, Germany.
- Department of Nephropathology, Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
- III Department of Medicine, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
- Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
ORCID-Profile: Lorenzo Catanese, Felicitas E Hengel, Harald Mischak, Justyna Siwy, Ralph Wendt
Förderung
- European Union
- Federal Ministry of Education and Research
- Bundesministerium für Bildung und Forschung (BMBF; Federal Ministry of Education and Research)
Zitieren
APA
Rupprecht, H., Catanese, L., Amann, K., Hengel, F. E., Huber, T. B., Latosinska, A., Lindenmeyer, M. T., Mischak, H., Siwy, J., Wendt, R., & Beige, J. (2024). Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers. International Journal of Molecular Sciences, 25(7), 3678. https://doi.org/10.3390/ijms25073678
Vancouver
Rupprecht H, Catanese L, Amann K, Hengel FE, Huber TB, Latosinska A, et al. Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers. International Journal of Molecular Sciences. 2024;25(7):3678. doi:10.3390/ijms25073678
BibTeX
@article{Rupprecht2024,
author = {Rupprecht, Harald and Catanese, Lorenzo and Amann, Kerstin and Hengel, Felicitas E and Huber, Tobias B and Latosinska, Agnieszka and Lindenmeyer, Maja T and Mischak, Harald and Siwy, Justyna and Wendt, Ralph and Beige, Joachim},
title = {Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {7},
pages = {3678},
doi = {10.3390/ijms25073678}
}
EUVIMED